Introduction {#s1}
============

It is increasingly recognised that new technological approaches are urgently required for infectious disease diagnosis, surveillance, and management in burgeoning domestic animal populations as livestock production intensifies across the globe (Thornton, [@B64]; Nabarro and Wannous, [@B46]; Animal Task Force, [@B3]). In this regard, new strategies have emerged that leverage peripheral blood gene expression to study host immunobiology and to identify panels of RNA transcript biomarkers that can be used as specific biosignatures of infection by particular pathogens for both animal and human infectious disease (Ramilo and Mejias, [@B54]; Mejias and Ramilo, [@B44]; Chaussabel, [@B9]; Ko et al., [@B35]; Holcomb et al., [@B27]). For example, we and others have applied this approach to bovine tuberculosis (BTB) caused by infection with *Mycobacterium bovis* (Meade et al., [@B43]; Killick et al., [@B34]; Blanco et al., [@B5]; Churbanov and Milligan, [@B13]; McLoughlin et al., [@B41]; Cheng et al., [@B11]). It is also important to note that peripheral blood transcriptomics using technologies such as microarrays or RNA-sequencing (RNA-seq) can be used to monitor changes in the physiological status of domestic animals due to reproductive status, diet and nutrition or stress (O\'Loughlin et al., [@B48]; Takahashi et al., [@B63]; Song et al., [@B61]; Kolli et al., [@B36]; Shen et al., [@B58]; de Greeff et al., [@B15]; Elgendy et al., [@B18]; Jégou et al., [@B30]).

During the last 15 years, a major hindrance to whole blood transcriptomics studies has emerged, which is the presence of large quantities of globin mRNA transcripts in peripheral blood from many mammalian species (Wu et al., [@B75]; Fan and Hegde, [@B19]; Liu et al., [@B39]). This is a consequence of abundant α globin and β globin mRNA transcripts in circulating reticulocytes, which in humans, may account for more than 95% of the total cellular mRNA content in these immature erythrocytes (Debey et al., [@B16]). Reticulocytes, in turn, account for 1--4% of the erythrocytes in healthy adult humans, which corresponds to between 5 × 10^7^ and 2 × 10^8^ cells per ml compared to 7 × 10^6^ cells per ml for leukocytes (Greer et al., [@B24]). Hence, globin transcripts can account for a substantial proportion of total detectable mRNAs in peripheral blood samples collected from humans and many other mammals (Bruder et al., [@B8]; Winn et al., [@B74]; Schwochow et al., [@B57]; Choi et al., [@B12]; Shin et al., [@B59]; Bowyer et al., [@B7]; Huang et al., [@B29]; Morey et al., [@B45]). In particular, for humans, more than 70% of peripheral blood mRNA transcripts are derived from the haemoglobin subunit alpha 1, subunit alpha 2 and subunit beta genes (*HBA1, HBA2*, and *HBB*) (Wu et al., [@B75]; Field et al., [@B20]; Mastrokolias et al., [@B40]).

The emergence of massively parallel transcriptome profiling for clinical applications in human peripheral blood---initially with gene expression microarrays, but more recently using RNA-seq---has prompted development of methods for the systematic reduction of globin mRNAs in total RNA samples purified from peripheral blood samples, including: oligonucleotides that bind to globin mRNA molecules with subsequent digestion of the RNA strand of the RNA:DNA hybrid (Wu et al., [@B75]); peptide nucleic acid (PNA) oligonucleotides that are complementary to globin mRNAs and block reverse transcription of these targets (Liu et al., [@B39]); the GLOBINclear™ system, which uses biotinylated oligonucleotides that hybridise with globin transcripts followed by capture and separation using streptavidin-coated magnetic beads (Field et al., [@B20]); and the recently introduced GlobinLock method that uses a pair of modified oligonucleotides complementary to the 3′ portion of globin transcripts and that block enzymatic extension (Krjutškov et al., [@B37]).

In the present study we use RNA-seq data generated from globin-depleted and non-depleted total RNA purified from human and porcine peripheral blood, in conjunction with non-depleted total RNA isolated from equine and bovine peripheral blood, for a comparative investigation of the impact of reticulocyte-derived globin mRNA transcripts on routine transcriptome profiling of blood in domestic cattle and horses. The primary objective of the present study to test the hypothesis that both cattle and horses exhibit significantly lower quantities of haemoglobin gene transcripts compared to humans and pigs.

Materials and methods {#s2}
=====================

Data sources
------------

RNA-seq data sets from human peripheral whole blood samples used for assessment of globin depletion and with parallel non-depleted controls (Shin et al., [@B59]) were obtained from the NCBI Gene Expression Omnibus (GEO) database (accession number GSE53655). A comparable RNA-seq data set from globin-depleted and non-depleted porcine peripheral whole blood was obtained directly from the study authors (Choi et al., [@B12]). A published RNA-seq data set (Ropka-Molik et al., [@B55]) from equine non-depleted peripheral whole blood was obtained from the NCBI GEO database (accession number GSE83404). Finally, bovine RNA-seq data from peripheral whole blood were generated by us as described below and can be obtained from the European Nucleotide Archive (ENA) database (PRJEB27764). A summary overview of the methodology used for the current study is shown in Figure [1](#F1){ref-type="fig"}.

![Schematic of the bioinformatics workflow for RNA-seq data acquisition, quality control, analysis, and interpretation.](fgene-09-00278-g0001){#F1}

Human, porcine and equine sample collection, globin depletion, and RNA-seq libraries
------------------------------------------------------------------------------------

Detailed information concerning ethics approval, sample collection, total RNA extraction, and RNA-seq library preparation and sequencing for the human, porcine, and equine data sets is provided in the original publications (Choi et al., [@B12]; Shin et al., [@B59]; Ropka-Molik et al., [@B55]). [Supplementary Table 1](#SM1){ref-type="supplementary-material"} provides summary information on the human, porcine and equine samples and RNA-seq libraries.

In brief, for the human samples, peripheral blood from six healthy subjects (three females and three males) was collected into PAXgene blood RNA tubes (PreAnalytiX/Qiagen Ltd., Manchester, UK). Total RNA, including small RNAs, was purified from the collected blood samples using the PAXgene Blood miRNA Kit (PreAnalytiX/Qiagen Ltd.) as described by Shin et al. ([@B59]). Human *HBA1, HBA2* and *HBB* mRNA transcripts were depleted from a subset of the total RNA samples using the GLOBINclear kit (Invitrogen™/Thermo Fisher Scientific, Loughborough, UK). RNA-seq data was then generated using 24 paired-end (PE) RNA-seq libraries (12 undepleted and 12 globin-depleted) generated from the six biological replicates and six identical technical replicates created from pooled total RNA across all six donor samples. The multiplexing and sequencing was then performed such that data for the 12 samples in each treatment group (undepleted and globin depleted) was generated from two separate lanes of a single flow cell twice, for a total of four sequencing lanes (Shin et al., [@B59]).

Porcine peripheral blood samples were collected from 12 healthy crossbred pigs \[Duroc × (Landrace × Yorkshire)\] using Tempus™ blood RNA tubes (Applied Biosystems™/Thermo Fisher Scientific, Warrington, UK) and total RNA was purified using the MagMAX™ for Stabilized Blood Tubes RNA Isolation Kit (Invitrogen™/Thermo Fisher Scientific) (Choi et al., [@B12]). Porcine *HBA* and *HBB* mRNA transcripts were subsequently depleted from a subset of the total RNA samples using a modified RNase H globin depletion method with custom porcine-specific antisense oligonucleotides for *HBA* and *HBB*. RNA-seq data was then generated from 24 PE RNA-seq libraries (12 undepleted and 12 globin-depleted).

Equine peripheral blood samples were collected using Tempus™ blood RNA tubes from 12 healthy Arabian horses (five females and seven males) at three different time points during flat racing training (Ropka-Molik et al., [@B55]). In addition, peripheral blood samples were collected from six healthy untrained Arabian horses (two females and four males). Total RNA was purified using the MagMAX™ for Stabilized Blood Tubes RNA Isolation Kit and 37 of the 42 total RNA samples were used to generate single-end (SE) libraries for RNA-seq data generation. Globin depletion for the equine samples was not performed prior to RNA-seq library preparation (Katarzyna Ropka-Molik, pers. comm.).

Bovine peripheral blood collection and RNA extraction
-----------------------------------------------------

Approximately 3 ml of peripheral blood from 10 age-matched healthy male Holstein-Friesian calves were collected into Tempus™ blood RNA tubes. The Tempus™ Spin RNA Isolation Kit (Applied Biosystems™/Thermo Fisher Scientific) was used to perform total RNA extraction and purification, following the manufacturer\'s instructions. RNA quantity and quality checking were performed using a NanoDrop™ 1,000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) and an Agilent 2,100 Bioanalyzer using an RNA 6,000 Nano LabChip kit (Agilent Technologies Ltd., Cork, Ireland). The majority of samples displayed a 260/280 ratio \>1.8 and an RNA integrity number (RIN) \>8.0 ([Supplementary Table 2](#SM2){ref-type="supplementary-material"}). Globin mRNA depletion was not performed on the total RNA samples purified from bovine peripheral blood samples.

Bovine RNA-seq library generation and sequencing
------------------------------------------------

Individually barcoded strand-specific RNA-seq libraries were prepared with 1 μg of total RNA from each sample. Two rounds of poly(A)^+^ RNA purification were performed for all RNA samples using the Dynabeads® mRNA DIRECT™ Micro Kit (Thermo Fisher Scientific) according to the manufacturer\'s instructions. The purified poly(A)^+^ RNA was then used to generate strand-specific RNA-seq libraries using the ScriptSeq™ v2 RNA-Seq Library Preparation Kit, the ScriptSeq™ Index PCR Primers (Sets 1 to 4) and the FailSafe™ PCR enzyme system (all sourced from Epicentre®/Illumina® Inc., Madison, WI, USA), according to the manufacturer\'s instructions.

RNA-seq libraries were purified using the Agencourt® AMPure® XP system (Beckman Coulter Genomics, Danvers, MA, USA) according to the manufacturer\'s instructions for double size selection (0.75 × followed by 1.0 × ratio). RNA-seq libraries were quantified using a Qubit® fluorometer and Qubit® dsDNA HS Assay Kit (Invitrogen™/Thermo Fisher Scientific), while library quality checks were performed using an Agilent 2,100 Bioanalyzer and High Sensitivity DNA Kit (Agilent Technologies Ltd.). Individually barcoded RNA-seq libraries were pooled in equimolar quantities and the quantity and quality of the final pooled libraries (three pools in total) were assessed as described above. Cluster generation and high-throughput sequencing of three pooled RNA-seq libraries were performed using an Illumina® HiSeq™ 2,000 Sequencing System at the MSU Research Technology Support Facility (RTSF) Genomics Core (<https://rtsf.natsci.msu.edu/genomics>; Michigan State University, MI, USA). Each of the three pooled libraries were sequenced independently on five lanes split across multiple Illumina® flow cells. The pooled libraries were sequenced as PE 2 × 100 nucleotide reads using Illumina® version 5.0 sequencing kits.

Deconvolution (filtering and segregation of sequence reads based on the unique RNA-seq library barcode index sequences; [Supplementary Table 2](#SM2){ref-type="supplementary-material"}) was performed by the MSU RTSF Genomics Core using a pipeline that simultaneously demultiplexed and converted pooled sequence reads into discrete FASTQ files for each RNA-seq sample with no barcode index mismatches permitted. The RNA-seq FASTQ sequence read data for the bovine samples were obtained from the MSU RTSF Genomics Core FTP server.

RNA-seq data quality control and filtering/trimming of reads
------------------------------------------------------------

Bioinformatics procedures and analyses were performed as described below for the human, porcine, equine, and bovine samples, except were specifically indicated. All of the bioinformatics workflow scripts were developed using GNU bash (version 4.3.48) (Free Software Foundation, [@B21]), Python (version 3.5.2) (Python Software Foundation, [@B51]), and R (version 3.4.0) (R Core Team, [@B52]). The scripts and further information are available at a public GitHub repository (<https://github.com/carolcorreia/Globin_RNA-sequencing>). Computational analyses were performed on a 32-core Linux Compute Server (4 × AMD Opteron™ 6220 processors at 3.0 GHz with 8 cores each), with 256 GB of RAM, 24 TB of hard disk drive storage, and with Ubuntu Linux OS (version 14.04.4 LTS). Deconvoluted FASTQ files (generated from SE equine RNA-seq libraries and PE RNA-seq libraries for the other species) were quality-checked with FastQC (version 0.11.5) (Andrews, [@B2]).

Using the ngsShoRT software package (version 2.2) (Chen et al., [@B10]), filtering/trimming consisted of: (1) removal of SE or PE reads with adapter sequences (with up to three mismatches); (2) removal of SE or PE reads of poor quality (i.e., at least one of the reads containing ≥25% bases with a Phred quality score below 20); (3) for porcine samples only, 10 bases were trimmed at the 3′ end of all reads; (4) removal of SE or PE reads that did not meet the required minimum length (70 nucleotides for human and equine, 80 nucleotides for porcine and 100 nucleotides for bovine). Filtered/trimmed FASTQ files were then re-evaluated using FastQC. Filtered FASTQ files were transferred to a 36-core/64-thread Compute Server (2 × Intel® Xeon® CPU E5-2697 v4 at 2.30 GHz with 18 cores each), with 512 GB of RAM, 96 TB SAS storage (12 × 8 TB at 7200 rpm), 480 GB SSD storage, and with Ubuntu Linux OS (version 16.04.2 LTS).

Transcript quantification
-------------------------

The Salmon software package (version 0.8.2) (Patro et al., [@B50]) was used in quasi-mapping-mode for transcript quantification. Sequence-specific and fragment-level GC bias correction was enabled and transcript abundance was quantified in transcripts per million (TPM) for each filtered library (multiple lanes from the same library were processed together) was estimated after mapping of SE or PE reads to their respective reference transcriptomes. As summarised in Table [1](#T1){ref-type="table"}, the NCBI RefSeq database is currently the only one to contain haemoglobin gene annotations for all species analysed. Hence, NCBI RefSeq reference transcript models were used for the human, porcine, equine, and bovine data sets. Detailed information about these reference transcriptomes is provided in [Supplementary Table 3](#SM3){ref-type="supplementary-material"}.

###### 

Status of current human, porcine, equine, and bovine haemoglobin gene annotations in the Ensembl, NCBI RefSeq, and UCSC databases.

                                              **Ensembl**                                                                                **NCBI RefSeq**                                                                               **UCSC table browser**
  ------------------------------------------- ------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ***Homo sapiens***                                                                                                                                                                                                                   
  Annotation release                          Human release 92 (April 2018)[^a^](#TN1){ref-type="table-fn"}                              NCBI *Homo sapiens* Annotation Release 109 (March 2018)[^b^](#TN2){ref-type="table-fn"}       hg38.refGene annotation track (last updated on May 2018)[^c^](#TN3){ref-type="table-fn"}^,^ [^d^](#TN4){ref-type="table-fn"}^,^ [^e^](#TN5){ref-type="table-fn"}
  Genome assembly used to derive annotation   GRCh38.p12, GCA_000001405.27, December 2017                                                GRCh38.p12, GCF_000001405.38, December 2017                                                   GRCh38, GCF_000001405.15, December 2013
  *HBA1*                                      Annotated with gene ID ENSG00000206172                                                     Annotated with Entrez Gene ID 3039                                                            Annotated with Entrez Gene ID 3039
  *HBA2*                                      Annotated with gene ID ENSG00000188536                                                     Annotated with Entrez Gene ID 3040                                                            Annotated with Entrez Gene ID 3040
  *HBB*                                       Annotated with gene ID ENSG00000244734                                                     Annotated with Entrez Gene ID 3043                                                            Annotated with Entrez Gene ID 3043
  ***Sus scrofa***                                                                                                                                                                                                                     
  Annotation release                          Pig release 92 (April 2018)[^a^](#TN1){ref-type="table-fn"}                                NCBI *Sus scrofa* Annotation Release 106 (May 2017)[^b^](#TN2){ref-type="table-fn"}           susScr3.refGene annotation track (last updated on May 2018)[^d^](#TN4){ref-type="table-fn"}^,^ [^e^](#TN5){ref-type="table-fn"}
  Genome assembly used to derive annotation   Sscrofa11.1, GCA_000003025.6, February 2017                                                Sscrofa11.1, GCF_000003025.6, February 2017                                                   Sscrofa11.1, GCF_000003025.6, February 2017
  *LOC110259958* (*HBA*)                      Absent from current annotation release, accessible via online search with ID 110259958.1   Annotated with Entrez Gene ID 110259958                                                       Absent
  *LOC100737768* (*HBA*)                      Absent from current annotation release, accessible via online search with ID 100737768.1   Annotated with Entrez Gene ID 100737768                                                       Absent
  *HBB*                                       Annotated with gene ID ENSSSCG00000014725                                                  Annotated with Entrez Gene ID 407066                                                          Annotated with Entrez Gene ID 407066
  ***Equus caballus***                                                                                                                                                                                                                 
  Annotation release                          Horse release 92 (April 2018)[^a^](#TN1){ref-type="table-fn"}                              NCBI *Equus caballus* Annotation Release 103 (January 2018)[^b^](#TN2){ref-type="table-fn"}   equCab2.refGene annotation track (last updated on May 2018)[^d^](#TN4){ref-type="table-fn"}^,^ [^e^](#TN5){ref-type="table-fn"}
  Genome assembly used to derive annotation   EquCab 2, GCA_000002305.1, September 2007                                                  EquCab3, GCF_002863925.1, May 2018                                                            EquCab 2, GCA_000002305.1, September 2007
  *HBA* (also known as *HBA1*)                Absent                                                                                     Annotated with Entrez Gene ID 100036557                                                       Annotated with Entrez Gene ID 100036557
  *HBA2*                                      Absent                                                                                     Annotated with Entrez Gene ID 100036558                                                       Annotated with Entrez Gene ID 100036558
  *HBB*                                       Annotated with gene ID ENSECAG00000010020                                                  Annotated with Entrez Gene ID 100054109                                                       Annotated with Entrez Gene ID 100054109
  ***Bos taurus***                                                                                                                                                                                                                     
  Annotation release                          Cow release 92 (April 2018)[^a^](#TN1){ref-type="table-fn"}                                NCBI *Bos taurus* Annotation Release 106 (May 2018)[^b^](#TN2){ref-type="table-fn"}           bosTau8.refGene annotation track (last updated on May 2018)[^d^](#TN4){ref-type="table-fn"}^,^ [^e^](#TN5){ref-type="table-fn"}
  Genome assembly used to derive annotation   UMD3.1, GCA_000003055.3, November 2009                                                     ARS-UCD1.2, GCF_002263795.1, April 2018                                                       UMD3.1.1, GCA_000003055.4, June 2014
  *HBA1*                                      Annotated as *GLNC1* with ID ENSBTAG00000026417                                            Annotated with Entrez gene ID 100140149                                                       Absent
  *HBA* (also known as *HBA2*)                Annotated as *GLNC1* with ID ENSBTAG00000026418                                            Annotated with Entrez Gene ID 512439                                                          Annotated with Entrez Gene ID 512439
  *HBB*                                       Annotated with gene ID ENSBTAG00000038748                                                  Annotated with Entrez Gene ID 280813                                                          Annotated with Entrez Gene ID 280813

*(Zerbino et al., [@B76])*.

*(O\'Leary et al., [@B47])*.

*(Kent et al., [@B33])*.

*(Karolchik et al., [@B32])*.

*(Tyner et al., [@B66])*.

Gene annotations and summarisation of TPM estimates at the gene level
---------------------------------------------------------------------

Using R (3.5.0) within the RStudio IDE (version 1.1.447) (R Studio Team, [@B53]) and Bioconductor (version 3.7 using BiocInstaller 1.30.0) (Gentleman et al., [@B22]), the GenomicFeatures (version 1.32.0) (Lawrence et al., [@B38]) and AnnotationDbi (version 1.42.1) (Pagès et al., [@B49]) packages were used to obtain corresponding gene and transcript identifiers from the NCBI RefSeq annotation releases pertinent to each species, as detailed in Table [1](#T1){ref-type="table"}. Using these identifiers, the tximport (version 1.8.0) package (Soneson et al., [@B60]) was used to import into R and summarise at gene level the TPM estimates obtained from the Salmon tool. A threshold of greater than or equal to 1 TPM across at least half of the total number of samples (≥12 for human and porcine, ≥18 for equine, and ≥5 for bovine) was applied in order to remove lowly expressed genes.

Data exploration, plotting, and summary statistics
--------------------------------------------------

Data wrangling and tidying from all species was performed using the following R packages: tidyverse (version 1.2.1) (Wickham, [@B69]), dplyr (version 0.7.5) (Wickham et al., [@B71]), tidyr (version 0.8.1) (Wickham and Henry, [@B72]), reshape2 (version 1.4.3) (Wickham, [@B68]), and magrittr (version 1.5) (Bache and Wickham, [@B4]). The ggplot2 (version 2.2.1) (Wickham and Chang, [@B70]), and ggjoy (version 0.4.1) (Wilke, [@B73]), packages were used for figure generation. Finally, the mean and standard deviation were calculated for the undepleted and globin-depleted groups in each species using the skimr (version 1.0.2) R package (McNamara et al., [@B42]).

Results and discussion {#s3}
======================

Status of human, porcine, equine, and bovine haemoglobin gene annotations
-------------------------------------------------------------------------

Annotation of the haemoglobin subunit alpha 1 and 2 genes (*HBA1* and *HBA2*, respectively) is well-established for the human genome; however, annotations for these genes in the porcine, equine, and bovine genomes are inconsistent across databases. As shown in Table [1](#T1){ref-type="table"}, the porcine *HBA* gene annotation is absent from Ensembl and the UCSC Table Browser. For the NCBI RefSeq database, this gene has been assigned to two loci (*LOC110259958* and *LOC100737768*) that have similar descriptions (haemoglobin subunit alpha and haemoglobin subunit alpha-like). Therefore, these NCBI LOC symbols were used.

Equine *HBA* (*HBA1*) and *HBA2* genes are absent from the current Ensembl annotation release. Similarly, bovine *HBA1* and *HBA* (*HBA2*) have been annotated as *GLNC1* in Ensembl, whereas *HBA1* is absent from the UCSC Table Browser annotation (Table [1](#T1){ref-type="table"}). In the NCBI RefSeq database, equine *HBA* (*HBA1*) is described as haemoglobin subunit alpha 1; and bovine *HBA* (*HBA2*) is described as haemoglobin subunit alpha 2, thus their descriptions are shown in parenthesis herein. In contrast to these observations, haemoglobin subunit beta (*HBB*) genes for the four species are well-annotated in Ensembl, NCBI RefSeq and UCSC Genome Browser databases (Table [1](#T1){ref-type="table"}).

At the time of writing, NCBI RefSeq is the only database that contains annotations for all three haemoglobin genes in all species analysed. Additionally, equine and bovine gene annotations are based on the latest genome assemblies (Table [1](#T1){ref-type="table"}). EquCab3 and ARS-UCD1.2 have incorporated major improvements compared to previous versions, including increased genome coverage (from 6.8 × and 9 × , to 80 × , respectively), and incorporation of PacBio sequencing reads (Kalbfleisch et al., [@B31]; Rosen et al., [@B56]).

Basic RNA-seq data outputs
--------------------------

Unfiltered SE (equine libraries) or PE (human, porcine, and bovine libraries) RNA-seq FASTQ files were quality-checked, adapter- and quality-filtered prior to transcript quantification. As shown in Table [2](#T2){ref-type="table"}, the human and porcine undepleted groups each had \~40 million (M) raw reads per library, whereas globin-depleted libraries showed a mean of \~37 and 31 M, respectively. Equine and bovine libraries, which did not include a globin depletion step had an average of 24 M raw reads and 21 M raw read pairs, respectively.

###### 

Summary of RNA-seq filtering/trimming and mapping statistics.

  **Species**        **Treatment**     **RNA-seq library type**   **Sequencing mode**   **Mean no. of reads (SE) or pairs (PE)**   **Mean no. of reads (SE) or pairs (PE) removed**   **Mean proportion of reads (SE) or pairs (PE) removed**   **Mean no. of observed fragments[^\*^](#TN6){ref-type="table-fn"}**   **Mean no. of mapped fragments[^\*^](#TN6){ref-type="table-fn"}**   **Average mapping rate**   **Reference source**
  ------------------ ----------------- -------------------------- --------------------- ------------------------------------------ -------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------------------- ------------------------------------------------------------------- -------------------------- ----------------------
  *Homo sapiens*     Undepleted        Inward unstranded          PE                    40,218,886                                 8,203,217                                          20.4%                                                     32,015,669                                                            25,593,239                                                          80.9%                      NCBI RefSeq
  *Homo sapiens*     Globin depleted   Inward unstranded          PE                    36,874,759                                 10,704,088                                         29.0%                                                     26,170,671                                                            20,371,624                                                          75.8%                      NCBI RefSeq
  *Sus scrofa*       Undepleted        Inward unstranded          PE                    39,036,515                                 4,613,991                                          11.8%                                                     28,685,437                                                            25,129,140                                                          87.7%                      NCBI RefSeq
  *Sus scrofa*       Globin depleted   Inward unstranded          PE                    31,339,886                                 3,899,427                                          12.4%                                                     22,867,049                                                            19,959,995                                                          87.3%                      NCBI RefSeq
  *Equus caballus*   Undepleted        Unstranded                 SE                    24,271,141                                 38,892                                             0.2%                                                      14,850,797                                                            11,387,774                                                          76.5%                      NCBI RefSeq
  *Bos taurus*       Undepleted        Inward stranded forward    PE                    20,495,983                                 3,474,597                                          17.0%                                                     17,021,386                                                            12,353,147                                                          72.6%                      NCBI RefSeq

*The Salmon tool categorises fragments as single read (for SE RNA-seq libraries) or a read pair (for PE RNA-seq libraries)*.

After adapter- and quality-filtering of RNA-seq libraries, an average of 20 and 29% read pairs were removed from the human undepleted and globin-depleted libraries, respectively. Conversely, \~12% of read pairs were removed from each of the porcine undepleted and globin-depleted libraries. For the undepleted equine and bovine RNA-seq libraries, an average of 0.2% reads and 17% read pairs were removed, respectively. Detailed information on filtering/trimming of RNA-seq libraries from all species, including technical replicates from libraries sequenced over multiple lanes, is presented in [Supplementary Table 4](#SM4){ref-type="supplementary-material"}. All data sets exhibited a mean mapping rate \>70% (Table [2](#T2){ref-type="table"}). [Supplementary Tables 5](#SM5){ref-type="supplementary-material"} contain sample-specific RNA-seq mapping statistics.

Transcript quantification
-------------------------

Transcript-level TPM estimates generated using the Salmon tool were imported into the R environment and summarised at gene level with the package tximport (Soneson et al., [@B60]). Gene-level TPM estimates represent the sum of corresponding transcript-level TPMs and provide results that are more accurate and comprehensible than transcript-level estimates (Soneson et al., [@B60]). In the current study, gene-level TPM estimates are referred as TPM.

Filtering of lowly expressed genes (see section Gene Annotations and Summarisation of TPM Estimates at the Gene Level) resulted in 12,951 genes expressed across all human samples, and represented 24% of 54,644 total annotated genes and pseudogenes. Porcine samples showed a total of 9,396 expressed genes (31% of 30,334 annotated genes and pseudogenes); and equine and bovine samples exhibited 12,724 (38% of 33,146) and 14,044 (40% of 35,143) expressed genes, respectively.

The density distribution of TPM values for the human and porcine samples improved after globin depletion; this is evident by the shift of gene detection levels toward greater log~10~ TPM values for the globin-depleted samples in Figure [2](#F2){ref-type="fig"}. In this regard, it is noteworthy that the undepleted bovine and equine samples also exhibited similar TPM density distributions to the human and porcine globin-depleted samples.

![Ridge plots showing density of sample gene-level transcripts per million (TPM). Results are shown from undepleted (purple) or globin-depleted (green) treatments.](fgene-09-00278-g0002){#F2}

Proportions of human and porcine haemoglobin gene transcripts in undepleted and depleted peripheral blood
---------------------------------------------------------------------------------------------------------

In line with previous reports (Field et al., [@B20]; Mastrokolias et al., [@B40]), the proportion of haemoglobin gene transcripts (*HBA1, HBA2*, and *HBB*) detected in undepleted human peripheral blood samples for the current study averaged 70% (Figure [3](#F3){ref-type="fig"} and [Supplementary Table 6](#SM6){ref-type="supplementary-material"}), which is lower than the mean proportion of 81% reported by Shin et al. ([@B59]). On the other hand, after depletion the human samples exhibited an identical reduction to a 17% proportion of globin sequence reads in both the present study and that of Shin et al. ([@B59]) (Figure [3](#F3){ref-type="fig"} and [Supplementary Table 6](#SM6){ref-type="supplementary-material"}).

![Average proportions of haemoglobin genes to total expressed genes from peripheral blood RNA-seq data in humans, pigs, horses, and cattle.](fgene-09-00278-g0003){#F3}

In the current study, for the undepleted porcine peripheral blood samples, the percentage of haemoglobin gene transcripts (*LOC110259958* \[*HBA*\], *LOC100737768* \[*HBA*\], and *HBB*) observed as a proportion of the total expressed genes was 72% (Figure [3](#F3){ref-type="fig"} and [Supplementary Table 6](#SM6){ref-type="supplementary-material"}), which is considerably larger than the mean of 46.1% reported in the original study (Choi et al., [@B12]). Similarly, after depletion, the porcine samples in the present study contained a mean proportion of 22% globin transcripts (Figure [3](#F3){ref-type="fig"} and [Supplementary Table 6](#SM6){ref-type="supplementary-material"}) compared to a mean proportion of 8.9% reported by Choi et al. ([@B12]). Additionally, Table [3](#T3){ref-type="table"} shows the mean TPM for each haemoglobin gene across undepleted or globin-depleted samples.

###### 

Summary statistics for haemoglobin gene-level transcripts per million (TPM).

  **Species**        **Gene symbol**          **Treatment**     **No. of samples**   **Mean TPM**   **Standard deviation**
  ------------------ ------------------------ ----------------- -------------------- -------------- ------------------------
  *Homo sapiens*     *HBA1*                   Undepleted        12                   191,209        16,601
  *Homo sapiens*     *HBA1*                   Globin depleted   12                   66,718         23,557
  *Homo sapiens*     *HBA2*                   Undepleted        12                   300,000        29,523
  *Homo sapiens*     *HBA2*                   Globin depleted   12                   79,818         31,259
  *Homo sapiens*     *HBB*                    Undepleted        12                   200,000        43,262
  *Homo sapiens*     *HBB*                    Globin depleted   12                   20,770         6,706
  *Sus scrofa*       *LOC110259958* (*HBA*)   Undepleted        12                   86             30
  *Sus scrofa*       *LOC110259958* (*HBA*)   Globin depleted   12                   13             13
  *Sus scrofa*       *LOC100737768* (*HBA*)   Undepleted        12                   243,864        31,605
  *Sus scrofa*       *LOC100737768* (*HBA*)   Globin depleted   12                   84,021         86,095
  *Sus scrofa*       *HBB*                    Undepleted        12                   476,284        52,939
  *Sus scrofa*       *HBB*                    Globin depleted   12                   136,172        128,232
  *Equus caballus*   *HBA* (*HBA1*)           Undepleted        37                   443            560
  *Equus caballus*   *HBA2*                   Undepleted        37                   653            789
  *Equus caballus*   *HBB*                    Undepleted        37                   1,024          1,144
  *Bos taurus*       *HBA1*                   Undepleted        10                   21             29
  *Bos taurus*       *HBA* (*HBA2*)           Undepleted        10                   1,101          1,102
  *Bos taurus*       *HBB*                    Undepleted        10                   532            469

A number of possible explanations, including the different approaches used for read mapping and transcript quantification, may account for the different proportions of haemoglobin gene transcript detected in human and porcine samples for the present study compared to the original studies (Choi et al., [@B12]; Shin et al., [@B59]). For the present study, a recently developed lightweight alignment method was adopted (Salmon and tximport), in contrast to the more traditional methodologies used in the original publications. Shin et al. ([@B59]) used the TopHat and Cufflinks software tools (Trapnell et al., [@B65]), while Choi et al. ([@B12]) implemented TopHat with Htseq-count (Anders et al., [@B1]). In addition to this, different gene annotations were used: NCBI *Homo sapiens* Annotation Release 109 and NCBI *Sus scrofa* Annotation Release 106 were used for the present study, while UCSC hg18 (*H. sapiens*) and Ensembl release 71 (*S. scrofa*) were used by Shin et al. ([@B59]) and Choi et al. ([@B12]), respectively.

Equine and bovine peripheral blood contains extremely low levels of haemoglobin gene transcripts
------------------------------------------------------------------------------------------------

The equine and bovine peripheral blood samples, which did not undergo globin depletion, had extremely low proportions of haemoglobin gene transcripts to total expressed genes: 0.21 and 0.17%, respectively (Figure [3](#F3){ref-type="fig"} and [Supplementary Table 6](#SM6){ref-type="supplementary-material"}). Notably, similar results have been reported in a transcriptomics study of bovine peripheral blood in response to vaccination against neonatal pancytopenia. In that study, 12 cows were profiled before and after vaccination (24 peripheral blood samples in total), and a mean proportion of 1.0% of RNA-seq reads were observed to map to the bovine α haemoglobin gene cluster on BTA25 or to the β haemoglobin gene cluster on BTA15 (Demasius et al., [@B17]). To the best of our knowledge, this is the first time that the average number of equine haemoglobin transcripts have been reported for RNA-seq data.

Finally, it is important to note that log~2~ TPM values for haemoglobin gene transcripts in the undepleted equine and bovine peripheral blood RNA samples are substantially lower than log~2~ TPM values for the globin-depleted human and porcine peripheral blood RNA samples (Figure [4](#F4){ref-type="fig"}). This is a direct consequence of extremely low levels of circulating reticulocytes in equine and bovine peripheral blood (Tablin and Weiss, [@B62]; Harper et al., [@B26]; Hossain et al., [@B28]; Cooper et al., [@B14]).

![Distribution of haemoglobin gene-level transcripts per million (TPM). Results are shown from undepleted (purple) or globin-depleted (green) treatments.](fgene-09-00278-g0004){#F4}

Conclusion {#s4}
==========

In light of our RNA-seq data analyses, we propose that globin mRNA transcript depletion is not a pre-requisite for transcriptome profiling of bovine and equine peripheral blood samples. This observation greatly simplifies the laboratory and bioinformatics workflows required for RNA-seq studies of whole blood collected from domestic cattle and horses. It will also be directly relevant to future work on blood-based biomarker and biosignature development in the context of infectious disease, reproduction, nutrition, and animal welfare. For example, transcriptomics of peripheral blood has been used extensively in development of new diagnostic and prognostic modalities for human tuberculosis (HTB) disease caused by infection with *Mycobacterium tuberculosis* (for reviews see: Blankley et al., [@B6]; Haas et al., [@B25]; Weiner and Kaufmann, [@B67]; Goletti et al., [@B23]). Therefore, as a consequence of this HTB research, comparable transcriptomics studies in cattle (Meade et al., [@B43]; Killick et al., [@B34]; Blanco et al., [@B5]; Churbanov and Milligan, [@B13]; McLoughlin et al., [@B41]; Cheng et al., [@B11]), and the ease with which RNA-seq can be performed in bovine peripheral blood, it should be feasible to develop transcriptomics-based biomarkers and biosignatures for bovine tuberculosis caused by *M. bovis* infection.
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